| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
180,310,000 |
| Market
Cap: |
41.24(B) |
| Last
Volume: |
799,597 |
Avg
Vol: |
864,930 |
| 52
Week Range: |
$191.51 - $228.9 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TIVDAK™, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers, and TUKYSA®, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
39,326 |
484,602 |
| Total Sell Value |
$0 |
$0 |
$8,245,949 |
$88,100,996 |
| Total People Sold |
0 |
0 |
7 |
8 |
| Total Sell Transactions |
0 |
0 |
18 |
70 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Simpson Todd E |
Chief Financial Officer |
• – – |
2012-09-05 |
4 |
AS |
$27.97 |
$1,258,650 |
D/D |
(45,000) |
70,762 |
|
- |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2012-09-05 |
4 |
OE |
$11.09 |
$502,073 |
D/D |
45,000 |
73,587 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2012-09-04 |
4 |
AS |
$26.54 |
$218,958 |
D/D |
(8,250) |
1,170,961 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2012-09-04 |
4 |
OE |
$3.30 |
$41,285 |
D/D |
8,250 |
1,172,961 |
|
- |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2012-08-27 |
4 |
AS |
$26.97 |
$836,070 |
D/D |
(31,000) |
70,762 |
|
- |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2012-08-27 |
4 |
OE |
$10.29 |
$329,491 |
D/D |
31,000 |
83,888 |
|
- |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2012-08-24 |
4 |
AS |
$26.97 |
$377,580 |
D/D |
(14,000) |
70,762 |
|
- |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2012-08-24 |
4 |
OE |
$10.29 |
$144,060 |
D/D |
14,000 |
84,762 |
|
- |
|
| Berger Franklin M |
Director |
– • – |
2012-08-23 |
4 |
OE |
$10.08 |
$202,800 |
D/D |
20,000 |
183,720 |
|
- |
|
| Reynolds Thomas C |
Chief Medical Officer |
• – – |
2012-08-20 |
4 |
A |
$0.00 |
$0 |
D/D |
26,000 |
57,601 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2012-08-20 |
4 |
A |
$0.00 |
$0 |
D/D |
74,250 |
1,170,961 |
|
- |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2012-08-20 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
70,762 |
|
- |
|
| Boerner Christopher S. |
SVP, Commercial |
• – – |
2012-08-20 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
33,753 |
|
- |
|
| Himes Vaughn B |
EVP, Technical Operations |
• – – |
2012-08-20 |
4 |
A |
$0.00 |
$0 |
D/D |
16,000 |
33,643 |
|
- |
|
| Dobmeier Eric |
Chief Operating Officer |
• – – |
2012-08-20 |
4 |
A |
$0.00 |
$0 |
D/D |
26,000 |
69,352 |
|
- |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2012-08-16 |
4 |
AS |
$25.97 |
$1,038,800 |
D/D |
(40,000) |
50,762 |
|
- |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2012-08-16 |
4 |
OE |
$10.29 |
$411,600 |
D/D |
40,000 |
90,762 |
|
- |
|
| Dobmeier Eric |
Chief Operating Officer |
• – – |
2012-08-13 |
4 |
AS |
$24.01 |
$600,290 |
D/D |
(25,000) |
43,352 |
|
- |
|
| Gryska David W |
Director |
– • – |
2012-08-10 |
4 |
OE |
$5.00 |
$37,500 |
D/D |
7,500 |
19,000 |
|
- |
|
| Gryska David W |
Director |
– • – |
2012-08-06 |
5 |
GD |
$0.00 |
$0 |
D/D |
500 |
11,000 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2012-08-02 |
4 |
AS |
$25.22 |
$11,550 |
D/D |
(458) |
1,096,711 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2012-08-02 |
4 |
OE |
$3.30 |
$1,511 |
D/D |
458 |
1,097,169 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2012-08-01 |
4 |
AS |
$26.04 |
$202,911 |
D/D |
(7,792) |
1,096,711 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2012-08-01 |
4 |
OE |
$3.30 |
$39,774 |
D/D |
7,792 |
1,098,711 |
|
- |
|
| Welch Daniel G |
Director |
– • – |
2012-07-27 |
4 |
OE |
$19.02 |
$57,060 |
D/D |
3,000 |
3,000 |
|
- |
|
1805 Records found
|
|
Page 46 of 73 |
|
|
